| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |